mebendazole and secnidazole

mebendazole has been researched along with secnidazole in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR1
Almirall, P; Cañete, R; Cimerman, S; Escobedo, AA; Gonzalez, ME; Pareja, A1
Brito, K; Cañete, R; Herrera, E; Kofoed, PE; Noda, AL; Rodríguez, M; Ursing, J1

Reviews

1 review(s) available for mebendazole and secnidazole

ArticleYear
Anti-
    Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22

    Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles

2020

Trials

1 trial(s) available for mebendazole and secnidazole

ArticleYear
A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.
    Annals of tropical medicine and parasitology, 2003, Volume: 97, Issue:5

    Topics: Adolescent; Antiprotozoal Agents; Child; Child, Preschool; Feces; Female; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Treatment Outcome

2003

Other Studies

1 other study(ies) available for mebendazole and secnidazole

ArticleYear
5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:8

    Topics: Adult; Aged; Antiprotozoal Agents; Cuba; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Feces; Female; Giardia lamblia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Middle Aged; Nitroimidazoles; Prospective Studies; Quinacrine; Treatment Outcome; Young Adult

2020